Literature DB >> 21442399

Cor triatriatum sinister with dilated coronary sinus from persistent left superior vena cava: a novel operative approach.

Tsuyoshi Kaneko1, Emmanouil Tsounias, William I Douglas, Felix W Tsai.   

Abstract

Persistent left superior vena cava is known to be associated with cor triatriatum. The persistent left superior vena cava drains into a dilated coronary sinus and can cause left atrial outflow obstruction by impinging on the posterior wall of the left atrium. Residual obstruction can persist, even after surgical resection of the cor triatriatum membrane. We describe a novel surgical treatment in a patient with cor triatriatum and persistent left superior vena cava.

Entities:  

Mesh:

Year:  2011        PMID: 21442399     DOI: 10.1007/s00246-011-9955-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  Repair of cor triatriatum associated with partially unroofed coronary sinus.

Authors:  J A van Son; R Autschbach; F W Mohr
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

2.  Cor triatriatum. Clinical presentation and operative results.

Authors:  G Salomone; R Tiraboschi; T Bianchi; F Ferri; M Crippa; L Parenzan
Journal:  J Thorac Cardiovasc Surg       Date:  1991-06       Impact factor: 5.209

3.  Repair of complex unroofed coronary sinus by anastomosis of left to right superior vena cava.

Authors:  J A van Son; J Hambsch; F W Mohr
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

4.  Cor triatriatum: presentation, diagnosis and long-term surgical results.

Authors:  Nelson Alphonso; Martin A Nørgaard; Andrew Newcomb; Yves d'Udekem; Christian P Brizard; Andrew Cochrane
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

  4 in total
  1 in total

1.  Prenatal diagnosis of cor triatriatum sinister associated with early pericardial effusion: A case report.

Authors:  Esther Cánovas; Eduardo Cazorla; Melanie Cristine Alonzo; Rebeca Jara; Leyre Álvarez; Duska Beric
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.